Back to Journals » International Journal of General Medicine » Volume 17
Development and Validation of a Nomogram for Predicting Lacunar Infarction in Patients with Hypertension
Authors Lu J, Pan H, Xing J, Wang B, Xu L, Ye S
Received 1 May 2024
Accepted for publication 25 July 2024
Published 6 August 2024 Volume 2024:17 Pages 3411—3422
DOI https://doi.org/10.2147/IJGM.S467762
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Vinay Kumar
Jun Lu,1,* Huiqing Pan,1,* Jingjing Xing,1 Bing Wang,1 Li Xu,2 Sheng Ye1,3
1Emergency Department, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, People’s Republic of China; 2Neurology Department, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, People’s Republic of China; 3School of Clinical Medicine, Wannan Medical College, Wuhu, Anhui, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Sheng Ye, Emergency Department, The Second Affiliated Hospital of Wannan Medical College, 10 Kangfu Road, Jinghu District, Wuhu, Anhui, People’s Republic of China, Email [email protected]
Background: A considerable proportion of hypertensive patients may experience lacunar infarction. Therefore, early identification of the risk for lacunar infarction in hypertensive patients is particularly important. This study aimed to develop and validate a concise nomogram for predicting lacunar infarction in hypertensive patients.
Methods: Retrospectively analyzed the clinical data of 314 patients with accurate history of hypertension in the Second Affiliated Hospital of Wannan Medical College from January 2021 to December 2022. All the patients were randomly assigned to the training set (n=220) and the validation set (n=94) with 7:3. The diagnosis of lacunar infarction in patients was confirmed using cranial CT or MRI. The independent risk factors of lacunar infarction were determined by Least absolute shrinkage and selection operator (LASSO) regression and multivariable logistic regression analysis. The nomogram was built based on the independent risk factors. The nomogram’s discrimination, calibration, and clinical usefulness were evaluated by receiver operating characteristics (ROC) curve, calibration curve, and decision curve analysis (DCA) analysis, respectively.
Results: The incidence of lacunar infarction was 34.50% and 33.00% in the training and validation sets, respectively. Five independent predictors were made up of the nomogram, including age (OR=1.142, 95% CI: 1.089– 1.198, P< 0.001), diabetes mellitus (OR=3.058, 95% CI: 1.396– 6.697, P=0.005), atrial fibrillation (OR=3.103, 95% CI: 1.328– 7.250, P=0.009), duration of hypertension (OR=1.130, 95% CI: 1.045– 1.222, P=0.002), and low-density lipoprotein (OR=2.147, 95% CI: 1.250– 3.688, P=0.006). The discrimination with area under the curve (AUC) was 0.847 (95% CI: 0.789– 0.905) in the training set and was a slight increase to 0.907 (95% CI: 0.838– 0.976) in the validation set. The calibration curve showed high coherence between the predicted and actual probability of lacunar infarction. Moreover, the DCA analysis indicated that the nomogram had a higher overall net benefit of the threshold probability range in both two sets.
Conclusion: Age, diabetes mellitus, atrial fibrillation, duration of hypertension, and low-density lipoprotein were significant predictors of lacunar infarction in hypertensive patients. The nomogram based on the clinical data was constructed, which was a useful visualized tool for clinicians to assess the risk of the lacunar infarction in hypertensive patients.
Keywords: lacunar infarction, nomogram, hypertension, lasso regression, predictive model
Introduction
Stroke is the second leading cause of death worldwide, including large arterial disease, cardiogenic cerebral infarction, and small lacunar vessel disease.1 Lacunar infarction (LI) accounts for 20–30% of ischemic strokes and is ignored due to its atypical clinical presentation.2 However, the asymptomatic infarct is primarily responsible for cognitive impairment, acute ischemic stroke, and depression, especially in middle-aged and elderly people.3,4 Therefore, early recognition of lacunar infarction needs to be widely concerned by society.
Hypertension was the main cardiovascular risk factor in cerebral infarction only for lacunar strokes and atherothrombotic infarctions,5 which impaired the structural and functional integrity of cerebral microcirculation, and aggravated cerebral microvascular endothelial dysfunction.6 The incidence of cerebral infarction in hypertensive patients was significantly increased, even with stable blood pressure control.7 Early identification of lacunar infarction in hypertensive patients was crucial, as it allowed clinicians to implement timely interventions, thereby improving patient outcomes and decreasing the incidence of long-term complications. In addition, accumulating studies indicated that age, diabetes, insulin resistance, and male gender have been the potential risk factors for lacunar infarction.8–10 However, there was no concise predictive model for lacunar infarction in hypertensive patients. Hence, it is essential to investigate the associated risk factors and construct a predictive model to assist clinicians in the early identification of lacunar infarction in hypertensive patients.
In this study, we aimed to find the sociodemographic, clinical predictors, and available biomarkers to screen the potential risk factors for lacunar infarction, using a retrospective cohort of hypertensive patients. Compared to other predictive models, the nomogram offered a visual representation, making it easier for medical professionals to apply in clinical practice. Therefore, we build a nomogram for clinicians to make a visualized and quick assessment to predict the possibility of lacunar infarction in hypertensive patients.
Methods
Study Design and Patients
This retrospective study enrolled 415 patients in the Second Affiliated Hospital of Wannan Medical College from January 2021 to December 2022. All patients were not required to agree with the use of their medical records. The clinical data of patients were strictly confidential. The study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Wannan Medical College and conducted in accordance with the principles of the Declaration of Helsinki (No. WYEFYLS202205). The ethics committee waived the requirement for patient informed consent due to the retrospective study design. All patient medical records were anonymized and strict confidentiality measures were implemented.
The inclusion criteria with patients were as follows: (1) age>18 years; (2) accurate history of hypertension; (3) completed a cranial computed tomography (CT) scan or magnetic resonance imaging (MRI) examination during the hospitalization; (4) patient with National Institute of Health Stroke Scale (NIHSS score) <5 on admission. The exclusion criteria were as follows: (1) incomplete medical records; (2) acute ischemic stroke or cerebral hemorrhage; (3) any other diagnosed inflammatory or infectious disorders of the neurological system; (4) malignancy or hematological disorders; (5) severe liver disease or chronic kidney failures.
According to the inclusion and exclusion criteria, a total of 314 patients were included in this study. Subsequently, we randomly assigned 220 patients to the training set and 94 patients to the validation set (the split ratio was 7:3) for nomogram construction and validation (Figure 1).
![]() |
Figure 1 Flow chart with the study. |
Observation Indicators and Definition
All patients completed a routine clinical evaluation, including age, gender, body mass index (BMI), comorbidities (diabetes mellitus, atrial fibrillation, coronary heart disease, chronic heart failure, and chronic obstructive pulmonary disease), and blood pressure monitoring. Clinical data included clinical symptoms (headache, vertigo, limb weakness), length of stay, and duration of hypertension. Laboratory examinations included red blood count (RBC), white blood count (WBC), hemoglobin (HB), platelet (PLT), total cholesterol (TC), low-density lipoprotein (LDL), triglyceride (TG), albumin (ALB), total bilirubin (TBIL), creatinine (CREA), blood urea nitrogen (BUN), uric acid (UA), alanine transaminase (ALT), serum potassium, serum sodium, and serum calcium. Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP)≥90 mmHg.11 BMI was calculated as dividing body weight (kg) by height (m2).12
Imaging
All enrolled patients underwent CT or MRI examinations within 24 hours of admission. The CT examinations were performed using a 64-section multidetector-row CT scanner (Model: Brilliance, Philips, The Netherlands). The scanning parameters were as follows: tube voltage of 120 kV, tube current ranging from 150 to 400 mA, slice thickness of 5 mm, pitch of 0.984, and a rotation time of 0.5 seconds. Image reconstruction was done using a standard algorithm with a reconstruction slice thickness of 1 mm.
The MRI examinations were performed using a 1.5-T MR scanner (Model: Optima MR360, GE healthcare, American). The scanning parameters were as follows: For T1-weighted imaging (T1WI), the parameters were TR (repetition time) =500 ms, TE (echo time) =10 ms, slice thickness =5 mm, and interslice gap=1 mm. For T2-weighted imaging (T2WI), the parameters were TR =3000 ms, TE =80 ms, slice thickness =5 mm, and interslice gap =1 mm. For FLAIR imaging, the parameters were TR=9000 ms, TE=120 ms, slice thickness=5 mm, and interslice gap=1 mm.
Lacunar infarction was characterized by a hypodense lesion measuring less than 2 cm in diameter, predominantly located in the basal ganglia, thalamus, or brainstem on CT scans, and appeared as hyperintense lesions on T2-weighted and FLAIR sequences, and hypointense lesions on T1-weighted sequences on MRI scans.13 The diagnosis of lacunar infarction was confirmed by experienced radiologists and neurologists.14
Statistical Analysis
Statistical analysis was performed with SPSS 25.0 (IBM Corporation, 2020, USA) and R software (version 3.6.2, http://www.r-project.org). The normal distribution for all continuous variables was tested using the Kolmogorov–Smirnov (K-S) method. Continuous variables with normal distribution were presented as mean± standard deviation, which was examined by using the independent samples t-test. The median (interquartile range) was used to present for continuous variables which were not normally distributed and were evaluated by the Mann–Whitney U-test. Categorical variables were expressed as frequency (percentage) and were examined by the chi-square test.
The least absolute shrinkage and selection operator (LASSO) method15 was used to select the best variables of risk factors to predict lacunar infarction in hypertensive patients. LASSO regression incorporated an L1 regularization term in the regression model, effectively shrinking some feature coefficients to zero. Variables with nonzero features were selected in the LASSO regression model. Independent predictive factors were identified by multivariate logistic regression analysis. Based on the results of multivariate logistic regression analysis, a predictive nomogram was developed to predict lacunar infarction. A calibration curve was drawn to assess the fitting degree between the actual and nomogram-prediction by using a calibration plot with bootstraps of 1000 resamples. The receiver operating characteristics (ROC) curve was used to evaluate the diagnostic value of the nomogram for discriminating. The net-benefit of the decision curve analysis (DCA) curve was further performed to estimate the clinical value of the nomogram. All statistical results performed were two-sided and regression coefficients reported 95% confidence intervals (CI). P<0.05 was considered statistically significant.
Results
Demographics and Clinical Data of Patients in the Training and Validation Sets
In total, 314 patients with hypertension were retrospectively included in this study, of which 220 constituted the training set and 94 constituted the validation set. 76(34.50%) patients in the training set and 31(33.00%) patients in the validation set were diagnosed with lacunar infarction, respectively. The characteristics and clinical data of the patients in the training set and the validation set were no significant differences (P>0.05) (Table 1).
![]() |
Table 1 Demographics and Clinical Characteristics with Patients of the Training and Validation Sets |
Variable Selection in the LASSO Regression and Multivariate Logistic Regression Analysis
Of the demographic characteristics, clinical data, comorbidities, and laboratory examinations, 5 potential variables were selected from 29 clinical features with nonzero coefficients in the LASSO binary logistic regression analysis. These factors included age, diabetes mellitus, atrial fibrillation, duration of hypertension, and low-density lipoprotein (Figure 2). Multivariate logistic regression analysis revealed that age (OR=1.142, 95% CI: 1.089–1.198, P<0.001), diabetes mellitus (OR=3.058, 95% CI: 1.396–6.697, P=0.005), atrial fibrillation (OR=3.103, 95% CI: 1.328–7.250, P=0.009), duration of hypertension (OR=1.130, 95% CI: 1.045–1.222, P=0.002), low-density lipoprotein (OR=2.147, 95% CI: 1.250–3.688, P= 0.006) were key predictors of lacunar infarction risk in patients with hypertension (Table 2).
![]() |
Table 2 Multivariate Analysis of Risk Factors for Lacunar Infarction in Patients with Hypertension |
Development of a Predictive Nomogram
A clinical nomogram was developed for predicting the probability of lacunar infarction based on the results from the multivariate logistic regression analysis, which included 5 variables (Figure 3). Drew a vertical line up to the “Point” axis to calculate the score of each variable, and the total score was summarized by the preliminary scores. Locate the total score on the “Total Points” axis, then the corresponding predicted probability of lacunar infarction could be located on the bottom axis. The higher the sum of points with each variable in the nomogram, the higher the risk of lacunar infarction.
The Discrimination of the Nomogram by ROC Curve
The AUC for the nomogram was 0.847 (95% CI: 0.789–0.905) in the training set (Figure 4A) and was confirmed to be 0.907 (95% CI: 0.838–0.976) in the validation set (Figure 4B), which demonstrated the model’s good discrimination. By contrast, the nomogram had high efficacy in detecting lacunar infarction in the training cohort, with accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 0.847, 0.803, 0.819, 0.701, and 0.887, respectively (Table 3).
![]() |
Table 3 Diagnostic Performances of Predictive Factors and Nomogram in the Training Set |
![]() |
Figure 4 ROC curves of nomogram. Notes: (A) ROC in the training set; (B) ROC in the validation set; (C) ROC in male patients; (D) ROC in female patients. |
Subgroup analysis revealed that the AUC of the nomogram for predicting lacunar infarction was 0.846 (95% CI: 0.778–0.913) in male patients (Figure 4C), and 0.893(95% CI: 0.837–0.949) in female patients (Figure 4D).
The Performance of the Nomogram
The performance of the nomogram was evaluated using the calibration curve. The calibration curves of the nomogram in the training set (Figure 5A) and validation set (Figure 5C) were plotted, which demonstrated a good agreement in both sets.
Clinical Use
The decision curve analysis for the nomogram showed that the use of this nomogram to predict the lacunar infarction risk yielded more net benefit than the scheme when the threshold probabilities of lacunar infarction in patients with hypertension ranged from 10% to 82% in the training set (Figure 5B), and 10% to 99% in the validation set (Figure 5D). These results indicated the predictive nomogram to be clinically useful.
Discussion
Lacunar infarction is a small deep infarction caused by penetrating arterial embolism, accounting for about 30% of all strokes.16,17 Early identification of risk factors for lacunar infarction was critical to stroke prevention.18 In this study, we investigated the risk factors of lacunar infarction in hypertensive patients. Several pivotal results were found in this study. First, the prolonged duration of hypertension had significantly associated with lacunar infarction. Second, we proved several traditional risk factors, such as age, diabetes mellitus, atrial fibrillation, and low-density lipoprotein were also independently associated with lacunar infarction. Third, we draw a nomogram model based on the traditional risk factors that can effectively predict lacunar infarction in hypertensive patients.
Lacunar infarcts are common in elderly patients with hypertension, with an annual incidence of 1,500,000 to 2,000,000 new cases in China.19 One study carried out in Dutch found the prevalence of lacunar infarction in people over 45 years old was 5.6%.20 In addition, the existing evidence found that the older the age, the higher the probability of lacunar infarction.21 Moreover, the probability of lacunar infarction increased with age in both males and females.22 The reason may be related to the long-term exposure to risk factors such as hypertension, arteriosclerosis, and diabetes as they grow older.23,24
Hypertension is the main cause of lacunar infarction and affects nearly half of Chinese adults.25,26 Hypertension-induced arteriolar hyaline degeneration, atherosclerosis, and fibrinoid necrosis ultimately leaded to lacunar infarction.26–28 Sun’s study showed that an increased incidence of lacunar infarction was associated with a longer duration of hypertension, which was consistent with our findings.26 In addition, they found that left atrial enlargement was closely associated with hypertension and was a risk factor for lacunar infarction. The longer duration of hypertension, the larger the diameter of the left atrium, and the higher the probability of lacunar infarction. There is no doubt that controlling blood pressure is the key to the prevention of lacunar infarction.23
Diabetes mellitus is a metabolic disease characterized by insulin resistance.29 The latest epidemiological study indicated that about 11% of adults in China were diagnosed with diabetes and 61 million people with underlying diabetes.30,31 The total number of people with diabetes mellitus worldwide is projected to increase to 366 million by 2030 due to population growth, aging, and rising obesity rates.32 Cardiovascular complications are the leading cause of death in patients with diabetes mellitus.33 Adults with diabetes mellitus have increased risks of stroke due to the vicious cycle that exists between hyperglycemia and microvascular dysfunction.34,35 One population-based study confirmed that subjects with diabetes mellitus had a two-fold higher risk of developing lacunar infarction.36 Mohammed’s study revealed that lacunar infarction was more common in diabetic patients.37 Our study also confirmed that diabetes mellitus was an independent risk factor for early clinical deterioration in lacunar infarction patients, which was consistent with Ferrari J’s study.38 Therefore, hypertensive patients complicated with diabetes mellitus should be more worthy of the attention of clinicians, and the risk of cardiovascular and cerebrovascular accidents would be significantly increased.39,40
Atrial fibrillation (AF) is the most common arrhythmia in aging patients.41 Cardiac fibrosis caused by atrial fibrillation can lead to atrial systolic dysfunction and increase the possibility of thrombosis.42 It has been recognized as an independent factor of poor prognosis in stroke patients.43 A 34-year follow-up study confirmed that stroke rates in patients with atrial fibrillation were nearly five times higher than in patients without atrial fibrillation.44 In addition, the 2017 American Heart Association/American Stroke Association (AHA/ASA) statement also pointed out that risk stratification of lacunar infarction in patients with atrial fibrillation is also important for the prevention of symptomatic cerebral infarction in the future.45 The mechanism of lacunar infarction in patients with atrial fibrillation may be related to microembolism from the left atrial appendage.46 Lacunar infarction caused by atrial fibrillation will make patients at greater risk of cognitive impairment and disability in the future.47,48 Additionally, in patients with atrial fibrillation, the development of new limb weakness or sensorimotor stroke should also consider the possibility of a lacunar syndrome caused by non-lacunar infarction.49 Therefore, we need to develop appropriate preventive and therapeutic strategies to reduce the incidence of atrial fibrillation. Furthermore, anticoagulants are commonly used drugs to prevent thromboembolism in patients with atrial fibrillation, which would play an important role in reducing future lacunar infarction in patients with atrial fibrillation.50
In our study, low-density lipoprotein was also a risk factor for lacunar stroke in hypertensive patients. Rutten-Jacobs’s study found that infarcts in the deep grey nuclei/internal capsule more often happened in lacunar infarction and were related to hyperlipidemia.51 Tang H’s study further confirmed that low-density lipoprotein level was an independent risk factor for single subcortical infarction in patients aged over 65.52 Moreover, low-density lipoprotein can be used as an indicator of disease progression in patients with lacunar infarction. Although the use of statins brings certain benefits to lacunar infarction,53 the range of low-density lipoprotein levels needed to be explored to prevent lacunar infarction in hypertensive patients.
However, our study has some limitations. First, the selection bias and recall bias were inevitable in this study. The diagnosis and the basic data of patients were retrospective collected based on an electronic medical record system. Second, the study was a single-center retrospective observational study, and the patients in the validation cohort were enrolled from the same local database, lacking validation with an external database from other institutes. Third, the study did not include treatment-related factors and stratify patients into different age groups, to explore their different risk factors for lacunar stroke. Undoubtedly, we need more clinical data to support our conclusions.
Conclusion
In conclusion, age, diabetes mellitus, atrial fibrillation, duration of hypertension, and low-density lipoprotein were significant predictors of lacunar infarction in hypertensive patients. The predictive model constructed based on the above five predictors demonstrated good predictive performance in predicting the probability of lacunar infarction, and this applied to both male and female patients. The nomogram has proven clinical utility and was useful for risk decision-making in patients with hypertension to prevent lacunar infarction.
Data Sharing Statement
The data and R codes are available from the corresponding author on reasonable request.
Ethical Approval
The study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Wannan Medical College and conducted in accordance with the principles of the Declaration of Helsinki (No. WYEFYLS202205).
Funding
This work was supported by the Key Research Fund Project of Wannan Medical College (grant number: WK2021ZF24) and the “Summit Plan” of the second affiliated hospital of Wannan Medical College (grant number: DFJH202207).
Disclosure
All authors declare no competing interests in the work.
References
1. Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in understanding the pathophysiology of lacunar stroke: a review. JAMA Neurol. 2018;75(10):1273–1281. doi:10.1001/jamaneurol.2018.1073
2. Regenhardt RW, Das AS, Ohtomo R, Lo EH, Ayata C, Gurol ME. Pathophysiology of lacunar stroke: history’s mysteries and modern interpretations. J Stroke Cerebrovasc Dis. 2019;28(8):2079–2097. doi:10.1016/j.jstrokecerebrovasdis.2019.05.006
3. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611–619. doi:10.1016/S1474-4422(07)70170-9
4. Chojdak-Lukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. Cerebral small vessel disease: a review. Adv Clin Exp Med. 2021;30(3):349–356. doi:10.17219/acem/131216
5. Arboix A, Roig H, Rossich R, Martínez EM, García-Eroles L. Differences between hypertensive and non-hypertensive ischemic stroke. Eur J Neurol. 2004;11(10):687–692. doi:10.1111/j.1468-1331.2004.00910.x
6. Ungvari Z, Toth P, Tarantini S, et al. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17(10):639–654. doi:10.1038/s41581-021-00430-6
7. Zhang J, Wu Y, Gao Z. Correlations of C-reactive protein (crp), interleukin-6 (il-6), and insulin resistance with cerebral infarction in hypertensive patients. Med Sci Monit. 2019;25:1506–1511. doi:10.12659/MSM.912898
8. Zhang J, Han F, Liang X, et al. Lacune and large perivascular space: two kinds of cavities are of different risk factors and stroke risk. Cerebrovasc Dis. 2020;49(5):522–530. doi:10.1159/000508732
9. Lee JE, Shin DW, Yun JM, et al. Insulin resistance is a risk factor for silent lacunar infarction. Stroke. 2016;47(12):2938–2944. doi:10.1161/STROKEAHA.116.014097
10. Shin DW, Lee KB, Seo JY, et al. Association between hypertriglyceridemia and lacunar infarction in type 2 diabetes mellitus. J Stroke Cerebrovasc Dis. 2015;24(8):1873–1878. doi:10.1016/j.jstrokecerebrovasdis.2015.04.030
11. Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020;70(691):90–91. doi:10.3399/bjgp20X708053
12. Cai X, Aierken X, Ahmat A, et al. A nomogram model based on noninvasive bioindicators to predict 3-year risk of nonalcoholic fatty liver in nonobese mainland Chinese: a prospective cohort study. Biomed Res Int. 2020;2020:8852198. doi:10.1155/2020/8852198
13. Hong NR, Seo HS, Lee YH, et al. The correlation between carotid siphon calcification and lacunar infarction. Neuroradiology. 2011;53(9):643–649. doi:10.1007/s00234-010-0798-y
14. Su JH, Meng LW, Dong D, et al. Noninvasive model for predicting future ischemic strokes in patients with silent lacunar infarction using radiomics. BMC Med Imaging. 2020;20(1):77. doi:10.1186/s12880-020-00470-7
15. Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512–5528. doi:10.1002/sim.3148
16. Kvistad CE, Oygarden H, Logallo N, et al. A stress-related explanation to the increased blood pressure and its course following ischemic stroke. Vasc Health Risk Manag. 2016;12:435–442. doi:10.2147/VHRM.S109032
17. Zhang C, Zhao X, Wang C, et al. Prediction factors of recurrent ischemic events in one year after minor stroke. PLoS One. 2015;10(3):e0120105. doi:10.1371/journal.pone.0120105
18. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220. doi:10.1161/CIR.0b013e31823ac046
19. Wang YJ, Zhang SM, Zhang L, et al. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther. 2012;18(2):93–101. doi:10.1111/j.1755-5949.2011.00290.x
20. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821–1828. doi:10.1056/NEJMoa070972
21. Zhou YN, Gao HY, Zhao FF, et al. The study on analysis of risk factors for severity of white matter lesions and its correlation with cerebral microbleeds in the elderly with lacunar infarction. Medicine. 2020;99(4):e18865. doi:10.1097/MD.0000000000018865
22. Ojha R, Huang D, An H, et al. Distribution of ischemic infarction and stenosis of intra- and extracranial arteries in young Chinese patients with ischemic stroke. BMC Cardiovasc Disord. 2015;15(1):158. doi:10.1186/s12872-015-0147-5
23. Wang H, Fu X, Ju J, et al. Acupuncture for patients recovering from lacunar infarction: a protocol for systematic review and meta-analysis. Medicine. 2021;100(25):e26413. doi:10.1097/MD.0000000000026413
24. Akinyemi RO, Owolabi MO, Ihara M, et al. Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa. Brain Res Bull. 2019;145:97–108. doi:10.1016/j.brainresbull.2018.05.018
25. Peng J, Laukkanen JA, Zhao Q, Wang L, Zhang X, Li G. Association of left atrial enlargement with ventricular remodeling in hypertensive Chinese elderly. Echocardiography. 2017;34(4):491–495. doi:10.1111/echo.13484
26. Sun T, Xie T, Zhang A, et al. Relation between left atrial structure and lacunar infarction in patients with hypertension. Aging. 2020;12(17):17295–17304. doi:10.18632/aging.103697
27. Meissner A. Hypertension and the brain: a risk factor for more than heart disease. Cerebrovasc Dis. 2016;42(3–4):255–262. doi:10.1159/000446082
28. Spence JD. Blood pressure gradients in the brain: their importance to understanding pathogenesis of cerebral small vessel disease. Brain Sci. 2019;9(2):21. doi:10.3390/brainsci9020021
29. Cui Y, Liang X, Gu H, et al. Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav. 2017;11(5):1248–1257. doi:10.1007/s11682-016-9583-9
30. Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018;61(6):1249–1260. doi:10.1007/s00125-018-4557-7
31. Zhang XX, Kong J, Yun K. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in china: a meta-analysis of observational studies. J Diabetes Res. 2020;2020:2315607. doi:10.1155/2020/2315607
32. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi:10.2337/diacare.27.5.1047
33. Cummings DM, Kirian K, Howard G, et al. Consequences of comorbidity of elevated stress and/or depressive symptoms and incident cardiovascular outcomes in diabetes: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Diabetes Care. 2016;39(1):101–109. doi:10.2337/dc15-1174
34. van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325–336. doi:10.1016/S2213-8587(19)30405-X
35. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death. Arch Intern Med. 2004;164(13):1422–1426. doi:10.1001/archinte.164.13.1422
36. Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care. 2006;29(10):2268–2274. doi:10.2337/dc06-0243
37. Aldriweesh MA, Alluhidan WA, Al Bdah BA, et al. Prevalence and clinical characteristics of lacunar stroke: a hospital-based study. Brain Sci. 2021;11(11):1466. doi:10.3390/brainsci11111466
38. Ferrari J, Knoflach M, Kiechl S, et al. Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology. 2010;74(2):136–141. doi:10.1212/WNL.0b013e3181c9188b
39. Ye S, Pan H, Li W, Wang B, Xing J, Xu L. High serum amyloid A predicts risk of cognitive impairment after lacunar infarction: development and validation of a nomogram. Front Neurol. 2022;13:972771. doi:10.3389/fneur.2022.972771
40. Bashir S, Terceno M, Buxo M, et al. Progressive lacunar strokes: a predictive score. J Stroke Cerebrovasc Dis. 2022;31(8):106510. doi:10.1016/j.jstrokecerebrovasdis.2022.106510
41. Poudel P, Xu Y, Cui Z, Sharma D, Tian B, Paudel S. Atrial fibrillation: recent advances in understanding the role of microRNAs in atrial remodeling with an electrophysiological overview. Cardiology. 2015;131(1):58–67. doi:10.1159/000375403
42. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63(22):2335–2345. doi:10.1016/j.jacc.2014.02.555
43. Staszewski J, Bilbin-Bukowska A, Szypowski W, Mejer-Zahorowski M, Stepien A. Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation. Arch Med Sci. 2021;17(6):1590–1598. doi:10.5114/aoms.2019.81669
44. Wolf RDA A, Kannel WB, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–988. doi:10.1161/01.STR.22.8.983
45. Smith EE, Saposnik G, Biessels GJ, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2017;48(2):e44–e71. doi:10.1161/STR.0000000000000116
46. Sugioka K, Takagi M, Sakamoto S, et al. Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study. Am Heart J. 2015;169(6):783–790. doi:10.1016/j.ahj.2015.03.016
47. Kalantarian S, Ay H, Gollub RL, et al. Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis. Ann Intern Med. 2014;161(9):650–658. doi:10.7326/M14-0538
48. Gaita F, Corsinovi L, Anselmino M, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol. 2013;62(21):1990–1997. doi:10.1016/j.jacc.2013.05.074
49. Arboix A, Massons J, García-Eroles L, Targa C, Comes E, Parra O. Clinical predictors of lacunar syndrome not due to lacunar infarction. BMC Neurol. 2010;10(1):31. doi:10.1186/1471-2377-10-31
50. Raparelli V, Proietti M, Cangemi R, Lip GY, Lane DA, Basili S. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2017;117(2):209–218. doi:10.1160/TH16-10-0757
51. Rutten-Jacobs LC, Markus HS. Vascular risk factor profiles differ between magnetic resonance imaging-defined subtypes of younger-onset lacunar stroke. Stroke. 2017;48(9):2405–2411. doi:10.1161/STROKEAHA.117.017813
52. Tang H, Wang Y, Cheng A, et al. Association between low-density lipoprotein cholesterol levels and proximal single subcortical infarction in comparison with distal single subcortical infarction. J Stroke Cerebrovasc Dis. 2020;29(11):105198. doi:10.1016/j.jstrokecerebrovasdis.2020.105198
53. Kim JS. Role of blood lipid levels and lipid-lowering therapy in stroke patients with different levels of cerebral artery diseases: reconsidering recent stroke guidelines. J Stroke. 2021;23(2):149–161. doi:10.5853/jos.2021.01249
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles

Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China
Jiang J, Zhong W, Huang W, Gao Y, He Y, Li X, Liu Z, Zhou H, Fu Y, Liu R, Zhang W
Therapeutics and Clinical Risk Management 2022, 18:579-591
Published Date: 17 May 2022
Establishment and Validation of a Predictive Nomogram for Hallux Valgus with Pain Under the Second Metatarsal
Bai Z, Cao X, Yang Y, Sun X, Dong Y, Wen J, Sun W
Journal of Pain Research 2022, 15:3523-3536
Published Date: 7 November 2022

A Nomogram for Predicting the Risk of Critical Limb Ischemia in Adults with Hypertension: A Retrospective Study
Xu D, Zhu X, Huo J, Xie X, Huang C, Fang X, Yin T
International Journal of General Medicine 2022, 15:8205-8216
Published Date: 18 November 2022

Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer
Shen J, Wang M, Li F, Yan H, Wang R, Zhou J
Breast Cancer: Targets and Therapy 2022, 14:375-389
Published Date: 30 November 2022

A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection
Qian C, Wu Q, Ruan Z, Liu F, Li W, Shi W, Ma L, Peng D, Yin H, Yao L, Li Z, Hong M, Xia L
Infection and Drug Resistance 2023, 16:201-215
Published Date: 7 January 2023